Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection

Journal of Hepatology

Volumn 55, Issue 4, 2011, Pages 770-776

  El Maouche, Diala ^a   Mehta, Shruti H ^b   Sutcliffe, Catherine ^b   Higgins, Yvonne ^a   Torbenson, Michael S ^a   Moore, Richard D ^a,b   Thomas, David L ^a   Sulkowski, Mark S ^a   Brown, Todd T ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bone mineral density; Hepatic fibrosis; Hepatitis C; HIV

Indexed keywords

ADULT; ARTICLE; BONE DENSITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HEPATITIS C; HIP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; RISK FACTOR; VIRUS REPLICATION;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; BONE DISEASES, METABOLIC; CELL LINE, TUMOR; FEMALE; FEMUR NECK; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VIRUS REPLICATION;

EID: 80052921809     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.01.035     Document Type: Article

References (43)

1. T.T. Brown, and R.B. Qaqish Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review AIDS 20 2006 2165 2174 (Pubitemid 44684707)
2. V.A. Triant, T.T. Brown, H. Lee, and S.K. Grinspoon Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large US healthcare system J Clin Endocrinol Metab 93 2008 3499 3504
3. T.T. Brown, G.A. McComsey, M.S. King, R.B. Qaqish, B.M. Bernstein, and B.A. da Silva Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen J Acquir Immune Defic Syndr 51 2009 554 561
4. C. Duvivier, S. Kolta, L. Assoumou, J. Ghosn, S. Rozenberg, and R.L. Murphy Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients AIDS 23 2009 817 824
5. J.E. Gallant, S. Staszewski, A.L. Pozniak, E. DeJesus, J.M. Suleiman, and M.D. Miller Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial JAMA 292 2004 191 201 (Pubitemid 38917996)
6. B. Grund, G. Peng, C.L. Gibert, J.F. Hoy, R.L. Isaksson, and J.C. Shlay Continuous antiretroviral therapy decreases bone mineral density AIDS 23 2009 1519 1529
7. McComsey G, Kitch D, Daar E, Tierney C, Jahed N, Tebas P, et al. Bone and Limb Fat Outcomes of ACTG A5224s, a Substudy of ACTG A5202: A Prospective, Randomized, Partially Blinded Phase III Trial of ABC/3TC or TDF/FTC with EFV or ATV/r for Initial Treatment of HIV-1 Infection. [Abstract. The 17th Conference on retroviruses and Opportunistic Infections, San Francisco, CA; 2010.
8. Moyle G, Givens N, Pearce H, Compston J. ASSERT. Effect of ART on bone turnover markers and bone density in HIV infected patients. [Abstract. 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, Philadelphia, PA; 2009.
9. Stellbrink H, Moyle G, Orkin C, al. E, editors. Assessment of safety and efficacy of Abacavir/Lamivudine and tenofovir/Emtricitabine in treatment-naive HIV-1 infected subjects. ASSERT: 48-week result. [Abstract. 12th European AIDS Conference; 2009 November 11-14; Cologne, Germany; 2009.
10. Tebas P, Umbleja T, Dube M, editors. Initiation of ART is associated with bone loss independent of thne specific ART regimen: Results of ACTG A5005s. [Abstract. 14th Conference on Retroviruses and Opportunistic Infections; 2007 February 26, 2007; Los Angeles Convention Center 2007.
11. M.G. van Vonderen, P. Lips, M.A. van Agtmael, E.A. Hassink, K. Brinkman, and S.E. Geerlings First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir AIDS 23 2009 1367 1376
12. J.E. Hay, and M.M. Guichelaar Evaluation and management of osteoporosis in liver disease Clin Liver Dis 9 2005 747 766 viii (Pubitemid 41406398)
13. I. Schiefke, A. Fach, M. Wiedmann, A.V. Aretin, E. Schenker, and G. Borte Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection World J Gastroenterol 11 2005 1843 1847 (Pubitemid 40520782)
14. Y. Arase, F. Suzuki, Y. Suzuki, N. Akuta, M. Kobayashi, and H. Sezaki Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus J Med Virol 82 2010 390 395
15. F. Collin, X. Duval, M.V. Le, L. Piroth, K.F. Al, and P. Massip Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults AIDS 23 2009 1021 1024
16. Dao C, Young B, Buchacz K, Baker R, Brooks J. Higher and Increasing Rates of Fracture among HIV-infected Persons in the HIV Outpatient Study Compared to the General US Population, 1994 to 2008 [Abstract. Abstracts of the 17th Conference on Retroviruses and Opportunistic Infections, San Francisco; 2010.
17. R.D. Moore Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort J Acquir Immune Defic Syndr Hum Retrovirol 17 1998 S38 S41
18. P. Bedossa, and T. Poynard An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group Hepatology 24 1996 289 293 (Pubitemid 26260021)
19. K. Ishak, A. Baptista, L. Bianchi, F. Callea, G.J. De, and F. Gudat Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
20. Hologic I. Hologic Data Dictionary and Calculations. In: 2000.
21. Hologic I. Ethnic Normals Reference Databases. In: 2007.
22. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. In.
23. R.V. Lo III, G. Guaraldi, M.B. Leonard, A.R. Localio, J. Lin, and G. Orlando Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men AIDS 23 2009 2191 2198
24. A.B. Araujo, T.G. Travison, S.S. Harris, M.F. Holick, A.K. Turner, and J.B. McKinlay Race/ethnic differences in bone mineral density in men Osteoporos Int 18 2007 943 953 (Pubitemid 46889553)
25. E.D. Daniels, J.M. Pettifor, C.M. Schnitzler, S.W. Russell, and D.N. Patel Ethnic differences in bone density in female South African nurses J Bone Miner Res 10 1995 359 367
26. D.P. DeSimone, J. Stevens, J. Edwards, J. Shary, L. Gordon, and N.H. Bell Influence of body habitus and race on bone mineral density of the midradius, hip, and spine in aging women J Bone Miner Res 4 1989 827 830 (Pubitemid 20065691)
27. M. Kleerekoper, D.A. Nelson, E.L. Peterson, M.J. Flynn, A.S. Pawluszka, and G. Jacobsen Reference data for bone mass, calciotropic hormones, and biochemical markers of bone remodeling in older (55-75) postmenopausal white and black women J Bone Miner Res 9 1994 1267 1276 (Pubitemid 24238358)
28. D.E. Meier, M.M. Luckey, S. Wallenstein, R.H. Lapinski, and B. Catherwood Racial differences in pre- and postmenopausal bone homeostasis: association with bone density J Bone Miner Res 7 1992 1181 1189
29. J.H. Tobias, D.G. Cook, T.J. Chambers, and N. Dalzell A comparison of bone mineral density between Caucasian, Asian and Afro-Caribbean women Clin Sci (Lond) 87 1994 587 591 (Pubitemid 24353475)
30. A.J. Taylor, L.C. Gary, T. Arora, D.J. Becker, J.R. Curtis, and M.L. Kilgore Clinical and demographic factors associated with fractures among older Americans Osteoporos Int 2010
31. A.C. Looker, H.W. Wahner, W.L. Dunn, M.S. Calvo, T.B. Harris, and S.P. Heyse Updated data on proximal femur bone mineral levels of US adults Osteoporos Int 8 1998 468 489 (Pubitemid 28486716)
32. El-Maouche D, Xu X, Cofrancesco J, Dobs A, Brown T. Low Bone Mineral Density in a Low-Income Inner-City Population [Abstract. J Bone Min Res, 2010.
33. C.C. Chen, S.S. Wang, F.S. Jeng, and S.D. Lee Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis? J Gastroenterol Hepatol 11 1996 417 421
34. F.J. Gallego-Rojo, J.L. Gonzalez-Calvin, M. Munoz-Torres, J.L. Mundi, R. Fernandez-Perez, and D. Rodrigo-Moreno Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis Hepatology 28 1998 695 699 (Pubitemid 28405418)
35. J. George, H.K. Ganesh, S. Acharya, T.R. Bandgar, V. Shivane, and A. Karvat Bone mineral density and disorders of mineral metabolism in chronic liver disease World J Gastroenterol 15 2009 3516 3522
36. A. Monegal, M. Navasa, N. Guanabens, P. Peris, F. Pons, and M.J. Martinez de Osaba Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation Calcif Tissue Int 60 1997 148 154 (Pubitemid 27058703)
37. C. Ding, V. Parameswaran, R. Udayan, J. Burgess, and G. Jones Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study J Clin Endocrinol Metab 93 2008 1952 1958 (Pubitemid 351656543)
38. T. Ali, D. Lam, M.S. Bronze, and M.B. Humphrey Osteoporosis in inflammatory bowel disease Am J Med 122 2009 599 604
39. B.A. Michel, D.A. Bloch, and J.F. Fries Predictors of fractures in early rheumatoid arthritis J Rheumatol 18 1991 804 808
40. P. Aukrust, C.J. Haug, T. Ueland, E. Lien, F. Muller, and T. Espevik Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy J Clin Endocrinol Metab 84 1999 145 150 (Pubitemid 29036693)
41. Brown TT, McComsey G. Changes in Bone Turnover, OPG/RANKL, and Inflammation with ART Initiation: A Comparison of Tenofovir- and Non-Tenofovir-Containing Regimens. [Abstract. 16th Conference of Retroviruses and Oppourtunistic Infections 2009.
42. H. Cheng, L.C. Gary, J.R. Curtis, K.G. Saag, M.L. Kilgore, and M.A. Morrisey Estimated prevalence and patterns of presumed osteoporosis among older Americans based on Medicare data Osteoporos Int 20 2009 1507 1515
43. R.G. Miller, B.H. Ashar, J. Cohen, M. Camp, C. Coombs, and E. Johnson Disparities in osteoporosis screening between at-risk African-American and white women J Gen Intern Med 20 2005 847 851 (Pubitemid 41725701)